Morning Movers 05/07: (INSM) (GTSI) (VRTX) (ASTC) Higher; (BSFT) (PETS) (CTSH) Lower
Tweet
Share
E-mail
Get Alerts INSM Hot Sheet
Join SI Premium – FREE
Insmed Incorporated (Nasdaq: INSM) 70.8% HIGHER; today announced that the U.S. FDA has lifted the clinical hold previously placed on ARIKACE® (liposomal amikacin for inhalation) in Cystic Fibrosis (CF) patients with Pseudomonas lung infections.
GTSI Corp. (Nasdaq: GTSI) 47.3% HIGHER; announced it has entered into a definitive agreement to be acquired through a cash tender offer at $7.75 per share by an affiliate of UNICOM® Systems, Inc.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) 43.5% HIGHER; reports an interim analysis of data from an ongoing Phase 2 study of VX-809 and KALYDECO (ivacaftor) that showed significant improvements in lung function (FEV1) among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, F508del. Click here to see the full report. The stock was also upgraded at ISI and JMP this morning.
Broadscoft, Inc. (NASDAQ: BSFT) 21.1% LOWER; reported Q1 EPS of $0.29, $0.06 better than the analyst estimate of $0.23. Revenue for the quarter came in at $38.3 million versus the consensus estimate of $36.96 million. Sees Q2 2012 EPS of $0.17-$0.23, versus the consensus of $0.28. Broadscoft, Inc. sees Q2 2012 revenue of $36-$38 million, versus the consensus of $38.5 million. Sees FY2012 EPS of $1.22-$1.32, versus the consensus of $1.26. Broadscoft, Inc. sees FY2012 revenue of $158-$162 million, versus the consensus of $162.2 million.
Petmed Express, Inc. (NASDAQ: PETS) 19.1% LOWER; reported Q4 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $55.9 million versus the consensus estimate of $52.05 million.
Cognizant Technology Solutions (NASDAQ: CTSH) 16.2% LOWER; reported Q1 EPS of $0.86, $0.07 better than the analyst estimate of $0.79. Revenue for the quarter came in at $1.71 billion versus the consensus estimate of $1.71 billion. Sees Q2 2012 EPS of $0.87, versus the consensus of $0.83. Cognizant Technology Solutions sees Q2 2012 revenue of $1.79 billion, versus the consensus of $1.84 billion. Sees FY2012 EPS of $3.62, versus the consensus of $3.45. Cognizant Technology Solutions sees FY2012 revenue of $7.34 million, versus the consensus of $7.54 million.
Astrotech Corp. (NASDAQ: ASTC) (SPACEHAB) 14.2% HIGHER; reported Q3 EPS of $0.05, versus ($0.02) reported last year. Revenue for the quarter came in at $10 million, versus $5.7 million reported last year.
Synacor (Nasdaq: SYNC) 13.2% HIGHER; continuing higher this week, extending a run which began on April 24th. The stock is up nearly 70 percent since then. Shares are flirting with the $13 level this morning.
GTSI Corp. (Nasdaq: GTSI) 47.3% HIGHER; announced it has entered into a definitive agreement to be acquired through a cash tender offer at $7.75 per share by an affiliate of UNICOM® Systems, Inc.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) 43.5% HIGHER; reports an interim analysis of data from an ongoing Phase 2 study of VX-809 and KALYDECO (ivacaftor) that showed significant improvements in lung function (FEV1) among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, F508del. Click here to see the full report. The stock was also upgraded at ISI and JMP this morning.
Broadscoft, Inc. (NASDAQ: BSFT) 21.1% LOWER; reported Q1 EPS of $0.29, $0.06 better than the analyst estimate of $0.23. Revenue for the quarter came in at $38.3 million versus the consensus estimate of $36.96 million. Sees Q2 2012 EPS of $0.17-$0.23, versus the consensus of $0.28. Broadscoft, Inc. sees Q2 2012 revenue of $36-$38 million, versus the consensus of $38.5 million. Sees FY2012 EPS of $1.22-$1.32, versus the consensus of $1.26. Broadscoft, Inc. sees FY2012 revenue of $158-$162 million, versus the consensus of $162.2 million.
Petmed Express, Inc. (NASDAQ: PETS) 19.1% LOWER; reported Q4 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $55.9 million versus the consensus estimate of $52.05 million.
Cognizant Technology Solutions (NASDAQ: CTSH) 16.2% LOWER; reported Q1 EPS of $0.86, $0.07 better than the analyst estimate of $0.79. Revenue for the quarter came in at $1.71 billion versus the consensus estimate of $1.71 billion. Sees Q2 2012 EPS of $0.87, versus the consensus of $0.83. Cognizant Technology Solutions sees Q2 2012 revenue of $1.79 billion, versus the consensus of $1.84 billion. Sees FY2012 EPS of $3.62, versus the consensus of $3.45. Cognizant Technology Solutions sees FY2012 revenue of $7.34 million, versus the consensus of $7.54 million.
Astrotech Corp. (NASDAQ: ASTC) (SPACEHAB) 14.2% HIGHER; reported Q3 EPS of $0.05, versus ($0.02) reported last year. Revenue for the quarter came in at $10 million, versus $5.7 million reported last year.
Synacor (Nasdaq: SYNC) 13.2% HIGHER; continuing higher this week, extending a run which began on April 24th. The stock is up nearly 70 percent since then. Shares are flirting with the $13 level this morning.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
